Connect with us

Health

Europe Sees Surge in Stimulant Drug Use, Wastewater Analysis Reveals

Published

on

A comprehensive study of wastewater across Europe has revealed a significant rise in the consumption of stimulant drugs, particularly MDMA, cocaine, and amphetamines, across 128 cities in 26 countries.

The research, conducted by the European Union Drugs Agency (EUDA) and the SCORE group, examined the drug-taking habits of approximately 68.8 million people by analyzing wastewater samples. This method enables scientists to measure drug residues excreted in urine, providing an estimate of consumption levels within a given population.

According to the EU, 87 million adults in Europe have used illicit drugs at least once in their lifetime. While cannabis and cocaine remain the most widely used substances, the study noted an increasing trend in the use of MDMA, heroin, synthetic drugs, and psychedelics. The analysis focused on five key stimulants: amphetamine, cocaine, methamphetamine, MDMA, and ketamine, in addition to cannabis.

Cocaine Use on the Rise

The report highlighted that while cocaine use remained relatively stable between 2011 and 2015, consumption began rising significantly from 2016 onward. Western and southern European cities, particularly in Belgium, the Netherlands, and Spain, reported the highest levels of cocaine residues in wastewater.

The 2024 findings show further increases, with 39 of the 72 cities analyzed reporting higher levels compared to 2023. Belgium, in particular, recorded a sharp increase, with Brussels and Antwerp showing significant spikes in daily cocaine consumption. In Brussels, the daily intake per 1,000 inhabitants reached 1,186.34 milligrams in 2024, nearly double the 2023 figure of 598.22 mg. The study also found that cocaine use peaks on Saturdays, indicating its predominant recreational use.

See also  Swedish Doctors Warn of Hormonal Cream Exposure in Children Following Alarming Cases

MDMA and Ecstasy Consumption

Belgium, along with Czechia, the Netherlands, and Portugal, also recorded high levels of MDMA use. While ecstasy consumption has fluctuated since 2016, longer-term trends indicate overall growth. Similar to cocaine, MDMA usage is predominantly linked to recreational settings, with consumption surging over the weekends.

Decline in Cannabis Use

Despite the rise in stimulant drug use, cannabis, which remains the most commonly used illicit drug in Europe with an estimated 22.8 million users, saw a decline in consumption across most cities in 2024 compared to previous years.

Wastewater analysis indicates that cannabis use is more widespread in southern and central European countries, particularly Spain, the Netherlands, and Portugal. While cannabis remains illegal in most European nations, certain exceptions exist. Germany, Luxembourg, and Malta have legalized cannabis under specific conditions, while nine other countries allow limited consumption.

Shifting Drug Policies

The European Drug Agency’s 2024 report highlighted the ongoing debate surrounding cannabis regulation in the region. While discussions on policy changes continue, the agency stated that the future direction of European drug laws remains uncertain.

With stimulant use increasing across major cities and cannabis consumption showing a shift, the findings from this study provide valuable insights into the evolving drug landscape in Europe.

Health

AI Model Surpasses Doctors in Key Medical Decision Tests, Study Finds

Published

on

A new study by researchers at Harvard Medical School and Beth Israel Deaconess Medical Center has found that advanced artificial intelligence systems can outperform human doctors in several medical reasoning tasks, including diagnosis and emergency care decisions.

The research compared physicians with large language models across a range of clinical scenarios. According to the findings, AI systems showed stronger performance in tasks such as identifying likely diagnoses, recommending treatment steps, and making decisions in emergency department settings where information is often limited.

Arjun Manrai, a co-senior author of the study, said the results demonstrate the rapid progress of AI in healthcare. He noted that the model surpassed both earlier systems and physician benchmarks in most tests. At the same time, he cautioned that better performance in controlled settings does not guarantee improved outcomes in real-world care.

The study evaluated OpenAI’s reasoning model, released in 2024, using a mix of published clinical cases and real-world emergency department data. Researchers presented the system with patient scenarios at different stages of care, from initial triage to later admission decisions. At each step, the AI was given only the information available at that point and asked to suggest diagnoses and next actions.

The results showed that the AI consistently outperformed doctors, especially in areas requiring structured reasoning and documentation. The largest gap appeared during the triage stage, when limited information makes decision-making more difficult. As additional data became available, both AI and physicians improved in accuracy, though the AI maintained an edge in many cases.

Peter Brodeur, a co-author of the study, said traditional testing methods such as multiple-choice questions are no longer sufficient to measure progress, as many AI models now achieve near-perfect scores. He added that newer evaluation approaches are needed to track further advances.

See also  New Drug Shows Promise in Treating Alzheimer’s Symptoms in Mice

Despite the promising results, researchers stressed that the use of AI in healthcare must be approached carefully. They warned that while a model may correctly identify a diagnosis, it could also recommend unnecessary tests or interventions that might carry risks for patients.

The study’s authors called for further trials in real clinical environments to better understand how AI tools perform in practice. They also highlighted the need for investment in infrastructure and clear frameworks to support the safe use of such technologies.

The findings come with some limitations, as the analysis focused on a specific version of the AI model, which has since been updated. Researchers said additional studies are needed to compare different systems and explore how doctors and AI can work together effectively in patient care.

Continue Reading

Health

New Study Reveals How Coffee May Help Protect the Body From Ageing

Published

on

A new study has uncovered a key biological mechanism that may explain why coffee has long been linked to healthier ageing and a lower risk of chronic disease.

Researchers at Texas A&M College of Veterinary Medicine & Biomedical Sciences found that compounds in coffee interact with a protein in the body known as NR4A1, a receptor involved in regulating stress responses, inflammation and cellular repair. The findings shed new light on how coffee may help protect the body from age-related decline.

For years, studies have associated regular coffee consumption with a longer life and reduced risk of conditions such as heart disease, cancer and cognitive decline. Until now, however, the biological processes behind those benefits have remained largely unclear.

The research team identified NR4A1 as a critical target for several naturally occurring compounds in coffee, particularly polyphenols and other polyhydroxylated substances. These compounds bind to the receptor and appear to influence how it functions.

NR4A1 acts as what scientists call a nutrient sensor, responding to dietary compounds and helping the body adapt to stress and damage. It plays an important role in controlling inflammation, maintaining energy balance and promoting tissue repair — all essential processes in healthy ageing.

Stephen Safe, one of the study’s lead researchers, said the findings provide a clearer understanding of coffee’s protective effects. He explained that NR4A1 helps limit damage when tissues are under stress, and that its absence can worsen the effects of injury or disease.

Laboratory tests showed that coffee compounds reduced cellular damage and slowed the growth of cancer cells. When researchers removed NR4A1 from the cells, those benefits disappeared, strongly suggesting that the receptor is central to coffee’s protective action.

See also  Survey Reveals Two in Five European Workers Face Mental Health Risks

The study also highlights that coffee’s health effects are likely driven by more than caffeine alone. Decaffeinated coffee has also been linked to improvements in learning and memory, indicating that other components, including polyphenols, may play a significant role.

Recent research has suggested that moderate consumption of caffeinated coffee may also reduce anxiety, improve attention and vigilance, and lower levels of inflammation.

Scientists caution that while the findings are promising, more research is needed to determine how significant the NR4A1 pathway is in humans and how it interacts with other biological systems.

Still, the discovery offers an important step toward understanding why coffee remains one of the most widely studied beverages in nutrition science. It also reinforces the idea that compounds found in everyday foods and drinks can play a meaningful role in supporting long-term health and resilience as people age.

Continue Reading

Health

Study Finds Rise in 11 Cancers Among Younger Adults in England

Published

on

A major study has found that rates of 11 types of cancer are increasing among younger adults in England, raising fresh concerns among researchers about factors driving the trend.

The study, conducted by the Institute of Cancer Research and Imperial College London, examined cancer diagnoses between 2001 and 2019 in adults aged 20 to 49. It identified rising incidence in a range of cancers, including breast, colorectal, pancreatic and kidney cancers.

The full list includes breast, colorectal, pancreatic, kidney, liver, gallbladder, thyroid, ovarian and endometrial cancers, as well as oral cancer and multiple myeloma, a form of blood cancer.

Researchers noted that for most of these cancers, rates have also increased among older adults, where cancer remains far more common. This suggests that some shared risk factors may be affecting multiple age groups.

Two cancers, however, stood out. Rates of colorectal and ovarian cancer rose only among younger adults, pointing to possible age-specific causes that are not yet fully understood.

Scientists examined a range of established cancer risk factors, including smoking, alcohol consumption, diet, physical activity and body weight. While these factors are known to contribute significantly to cancer risk, they do not appear to fully explain the recent rise in cases among younger people.

In fact, many of these traditional risk factors have either remained stable or improved over recent decades. Smoking rates have declined, alcohol consumption has generally fallen or levelled off, physical inactivity has decreased, and intake of red and processed meat has dropped.

Obesity was the notable exception. Rates of obesity have risen steadily across all adult age groups and remain a significant contributor to cancer risk. Even so, researchers found that obesity alone could not account for the broader increase in cancer diagnoses among younger adults.

See also  Women's Underwear Found to Contain Harmful Chemicals in New Lab Tests

This was particularly true for cancers commonly associated with excess body weight, such as bowel, kidney, pancreatic, liver, gallbladder and endometrial cancers. While rising obesity may be playing a role, it does not fully explain the trend.

The findings suggest that other factors may be contributing. Researchers say further investigation is urgently needed into possible causes, including environmental exposures, changes in diet or lifestyle during childhood, and other early-life influences.

They also pointed to the possibility that improved diagnostic tools, increased screening and greater public awareness may be leading to more cases being detected.

Public health experts say the study highlights the need for continued prevention efforts, particularly in tackling smoking and obesity, which remain more common in disadvantaged communities. As researchers work to better understand the causes, the rise in cancer among younger adults is likely to remain an important area of focus for health authorities.

Continue Reading

Trending